Smart sensor could help kidney transplant patients tame diabetes

NCT ID NCT04783441

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a continuous glucose monitor (CGM) helps kidney transplant recipients with type 2 diabetes keep their blood sugar in a healthy range. Eighty adults who received a kidney transplant within the past year and use insulin will wear a Dexcom G6 sensor that tracks glucose levels 24/7. The goal is to see if real-time monitoring improves 'time in range' compared to a blinded sensor that only shows data after 10 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dexcom G6 continuous glucose monitor
What this could lead to
If it works, this could show that continuous glucose monitoring helps kidney transplant patients keep their blood sugar in a healthy range more consistently.
What could go wrong
This is a small, early-stage study with only 80 participants, so results may not apply to everyone. The device itself does not treat diabetes—it only tracks glucose levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UC Davis Health

    RECRUITING

    Sacramento, California, 95817, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.